Causes

Causes of Coronary Artery Disease

Fatty plaque builds in the arteries that feed the heart over years, and a case-control study of 15,152 heart attacks and 14,820 matched controls in 52 countries found that nine factors together accounted for most of the risk, 90% in men and 94% in women¹.

Cause	How It Contributes to Coronary Artery Disease	What Helps
Atherogenic cholesterol particles	The ratio of apolipoprotein B to apolipoprotein A1 carried the largest single share of heart attack risk in that study, a population attributable risk of 49.2% for the top four quintiles against the lowest¹, and lowering LDL cholesterol lowers events roughly in proportion to how far it falls, about a fifth fewer major vascular events a year per 39 mg/dL (1 mmol/L)⁷	The Mediterranean or plant-forward pattern in the diet section, plus the lipid-lowering treatment your clinician prescribes; diet and medicine have not been compared head to head, and nothing here is a reason to stop prescribed treatment
Smoking	Current smoking carried an odds ratio of 2.87 against never smoking, with a population attributable risk of 35.7% for current and former smokers¹, and the NHS names smoking as a cause of the fatty buildup in the arteries that underlies this disease⁹	Stopping smoking, with help from your clinical team; it is the change with the largest effect on this list that a person makes themselves
High blood pressure	A history of high blood pressure carried an odds ratio of 1.91 and a population attributable risk of 17.9%¹	Blood pressure treatment from your prescriber, plus the sodium and potassium advice on our high blood pressure guide and the food pattern in the diet section here
Diabetes and abdominal obesity	Diabetes carried an odds ratio of 2.37 and a population attributable risk of 9.9%, and abdominal obesity a population attributable risk of 20.1% for the top two tertiles of waist to hip ratio against the lowest¹	Glucose treatment from your clinical team, and the pattern in the diet section: whole foods, olive oil, nuts, vegetables and legumes in place of refined carbohydrate and sugar
Too little fruit and vegetables, too little activity	Not eating fruit and vegetables daily carried a population attributable risk of 13.7%, and lack of regular physical activity 12.2%¹; exercise-based cardiac rehabilitation lowered cardiovascular deaths by about a quarter in 85 trials⁸	The vegetables, legumes, nuts and olive oil listed in the diet section, and the aerobic and resistance training described in the treatment section
Psychosocial stress	Psychosocial factors, covering stress at home and work, financial stress, life events and depression, carried an odds ratio of 2.67 and a population attributable risk of 32.5%¹	The stress management, sleep and activity measures in the treatment section; where low mood or persistent stress is the issue, say so to your clinician rather than treating it as a lifestyle detail

Treatment Comparison

Conventional and Holistic Treatment for Coronary Artery Disease

🌿 HOLISTIC

💊 CONVENTIONAL

🌿

Holistic / Functional Approach

Mediterranean diet with fatty fish, magnesium, K2, exercise, stress reduction, gut microbiome optimization

Plaque Regression

In one small randomized trial (48 patients), an intensive lifestyle program reduced coronary stenosis by 1.75 percentage points at 1 year (a 4.5% relative improvement) while controls worsened²

Event Reduction

Mediterranean diet: about 28% fewer major cardiovascular events in high-risk adults without heart disease at entry (PREDIMED)²⁰

Timeline

LDL response is checked 4 to 12 weeks after starting a statin¹²; in one lifestyle trial, plaque change was larger at 5 years than at 1 year²

Advantage

Addresses inflammation, insulin resistance and lipids together

Full Holistic Approach Includes

Mediterranean or whole-food plant-based diet, the most extensively studied dietary patterns for CV protection
Omega-⁠3 EPA/DHA, not recommended for preventing heart attacks and strokes (for high triglycerides, ask your prescriber about prescription omega-⁠3): supplement trials have not shown cardiovascular benefit¹³
Eliminate ultra-processed foods, refined sugars and trans fats
Resistance training + aerobic exercise, 150 min/week moderate aerobic + 2x/week resistance
Berberine (500 mg 2 to 3x/day), which lowers LDL, triglycerides and glucose via the AMPK pathway; it interacts with many prescription medicines, so check with your prescriber first
Vitamin K2 (MK-⁠7) 100 to 200 mcg/day, studied for arterial calcification with mixed results. If you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonizes warfarin, and changing your intake destabilizes the INR.
Magnesium (300 to 400 mg/night), vasodilatory, antiarrhythmic, BP-lowering. The upper intake level for supplemental magnesium¹⁴ is 350 mg/day; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Stress management, meditation, breathwork, time outdoors
Sleep 7 to 9 hours: short sleep went with 1.48 times the risk of developing or dying of coronary heart disease in pooled prospective studies, and long sleep with 1.38 times¹⁵; treat sleep apnea aggressively
High-fiber diet; TMAO, a gut-derived metabolite, is associated with cardiovascular risk in observational studies

⚠️ Important: Holistic approaches complement but don't replace acute cardiac care. If you've had a heart attack, stent or bypass, work WITH your cardiologist on lifestyle, and never discontinue medications without clinical guidance.

💊

Conventional / Medical Approach

Statins, PCSK9 inhibitors, ezetimibe, antiplatelets, beta-blockers, ACE inhibitors, stents, bypass

First-Line

High-intensity statin (atorvastatin 40 to 80 mg, rosuvastatin 20 to 40 mg) for established CAD¹²

LDL Targets

<55 mg/dL for coronary disease at very high risk of further events; for everyone else with coronary disease, the goal is set by risk level with your clinician¹⁶

Acute Intervention

PCI (stent) for active ischemia; CABG (bypass) for multi-vessel disease

Side Effects

Statins: muscle aches¹⁷ (far less often in blinded trials than in open-label use), liver enzyme elevation, small new-onset diabetes risk; CoQ10 evidence is mixed

Conventional Approach Includes

Statins (atorvastatin, rosuvastatin), cornerstone therapy. Lower LDL cholesterol, and major vascular events fall by about a fifth for each 39 mg/dL (1 mmol/L) it comes down⁷
Ezetimibe, which blocks intestinal cholesterol absorption; added to a statin after an acute coronary syndrome it lowered average LDL cholesterol from 69.5 to 53.7 mg/dL and modestly reduced cardiovascular events¹⁸
PCSK9 inhibitors (alirocumab, evolocumab), injectable; large LDL reduction. Expensive; used for high-risk patients
Aspirin¹⁹ (low-dose), secondary prevention only (after established CAD). No longer recommended for primary prevention
P2Y12 inhibitors (clopidogrel, ticagrelor), after PCI or ACS
Beta-blockers, which reduce mortality post-MI and control angina
ACE inhibitors / ARBs, for hypertension, heart failure and post-MI remodeling
Coronary stents (PCI), which relieve symptoms in stable CAD; life-saving in ACS
Coronary artery bypass grafting (CABG), for severe multi-vessel disease or left main stenosis

⚠️ Important: Stents in stable CAD (ISCHEMIA trial) have not been shown to reduce death or MI compared to medical therapy + lifestyle. Used mainly in acute settings and for angina that persists despite medication. Discuss risks/benefits with cardiologist.

Supplement Protocol

Evidence-Based Supplements for Coronary Artery Disease

These supplements target the multiple pathways driving atherosclerosis: lipids, inflammation, oxidative stress, mitochondrial function and endothelial health.

Supplement	What it is for	Typical range	Timing	Notes & cautions
Omega-⁠3 EPA/DHA	Anti-inflammatory and triglyceride-lowering. Be careful reading across from the trials. Prescription icosapent ethyl at 4 g/day reduced major cardiac events by 25% in REDUCE-IT, in statin-treated patients with high triglycerides. Ordinary fish oil supplements are not that drug, and the two large trials that tested them, VITAL and ASCEND, found no cardiovascular benefit.¹³	Not recommended for preventing heart attacks and strokes (the trials used 1 g a day)	Not applicable	If your triglycerides are high, ask your prescriber about prescription omega-⁠3. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day²², so check any fish oil supplement with your clinician first.
CoQ10 (Ubiquinol)	Mitochondrial cofactor. Statins lower circulating CoQ10. Whether supplementing helps statin-related muscle symptoms is genuinely unsettled: one meta-analysis of 7 trials found no benefit; another of 12 trials found it reduced muscle pain. Worth trying if statin muscle symptoms are limiting, with the expectation that it may do nothing. Separately, Q-SYMBIO suggested fewer events in heart failure, which is a different population from coronary disease.²³	100 to 300 mg ubiquinol/day	With fat meal	An option if statin muscle symptoms are limiting; evidence is mixed²³. Ubiquinol form better absorbed than ubiquinone. CoQ10 may interact with some blood thinners and with insulin, so check with your prescriber first if you take either²⁴.
Magnesium Glycinate	Vasodilatory, BP-lowering, antiarrhythmic, antiplatelet. Magnesium deficiency is a CV risk factor in its own right.	300 to 400 mg elemental/night	Before bed	Glycinate or threonate. Many Americans eat less than the recommended amount. Especially important if on diuretics. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Vitamin K2 (MK-⁠7)	Activates Matrix Gla protein, which inhibits arterial calcification. In the Rotterdam Study, people in the top third of dietary vitamin K2 intake had 57% lower coronary heart disease mortality than the bottom third, an observational finding about food rather than supplements²⁵.	100 to 200 mcg MK-⁠7/day	With fat meal	Take with vitamin D3. If you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it.
Berberine	Pooled placebo-controlled trials in metabolic syndrome found it lowered LDL cholesterol by about 19 mg/dL (0.5 mmol/L), triglycerides by about 33 mg/dL (0.37 mmol/L) and fasting glucose²⁶. Activates AMPK pathway. Studied for lipid lowering in metabolic syndrome, though comparative data against prescription therapy is limited.	500 mg 2 to 3x/day	With meals	GI tolerance improves over 2 weeks. Monitor when combined with prescription diabetes meds. Berberine inhibits CYP3A4 and P-glycoprotein, so it can raise blood levels of many prescription medicines, and it lowers blood sugar on its own. Check with your prescriber before starting it, particularly alongside glucose-lowering medication, an anticoagulant, an immunosuppressant or any drug with a narrow safe range. Not for use in pregnancy or breastfeeding.
Aged Garlic Extract	Reduces BP modestly, slows coronary calcification (multiple imaging studies), improves endothelial function. Aged garlic extract is the preparation used in the coronary calcium trials.	1,200 to 2,400 mg/day	With meals, split doses	Aged garlic extract has been studied more than raw garlic. Mild blood-thinning; stop before surgery. Can add to the effect of antiplatelet and anticoagulant medicines; check with your prescriber first.
Curcumin (Turmeric Extract)	Anti-inflammatory, improves endothelial function, modestly lowers triglycerides.	500 to 1,000 mg 2x/day	With food	Can add to the effect of antiplatelet and anticoagulant medicines; check with your prescriber first. Liver injury has been reported mainly with high-dose, high-absorption formulations such as those with piperine, so stop and seek advice if you notice dark urine or yellowing skin.
L-Citrulline / Beet Nitrates	Both increase nitric oxide availability, improve endothelial function, lower BP and increase exercise capacity. In pooled short trials, nitrate or beet juice lowered systolic pressure by about 4.4 mmHg²⁷.	Citrulline 3 to 6 g/day OR beet juice about 1 to 2 cups (250 to 500 mL) a day	30 to 60 min before exercise or with meals	Beets turn urine pink, harmless. Citrulline more reliable than arginine.
Vitamin D3	Correcting a deficiency. In a large randomized trial, vitamin D supplements did not lower heart attacks or other major cardiovascular events against placebo²⁸.	Set the dose with your clinician; most adults need no blood test first	With fat meal	Some people pair it with K2.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.³¹ This page is nutrition education, not medical advice, and it does not replace your doctor. Two things to be clear about. First, nothing on this page is a substitute for treatment of coronary artery disease, and none of it is a reason to stop or reduce a statin, an antiplatelet or a blood pressure medicine. Those decisions belong with your cardiologist, and stopping them abruptly carries real risk. Second, chest pain that is new, worsening or occurring at rest, or that comes with breathlessness, sweating or nausea, is an emergency. Call emergency services. Do not look for it on a nutrition page.

On what drives a first heart attack: the INTERHEART case-control study enrolled 15,152 people with a first heart attack and 14,820 matched controls in 52 countries. Nine factors (the apolipoprotein B to A1 ratio, smoking, high blood pressure, diabetes, abdominal obesity, psychosocial factors, daily fruit and vegetables, alcohol and regular physical activity) together accounted for 90% of the population attributable risk in men and 94% in women, consistently across regions, sexes and ages, PubMed 15364185. ↩
On intensive lifestyle change and coronary stenosis: a small randomized trial of 48 patients with moderate to severe coronary heart disease tested a 10% fat whole-food vegetarian diet, aerobic exercise, stress management, smoking cessation and group support, without lipid-lowering drugs; 35 patients completed the 5-⁠year imaging. Average percent diameter stenosis fell by 1.75 percentage points after 1 year, a 4.5% relative improvement, and by 3.1 points after 5 years, while in the control group it rose by 2.3 and 11.8 points, PubMed 9863851. ↩
On the Mediterranean dietary pattern: PREDIMED, N Engl J Med. 2018;378:e34 (republished after reanalysis), found lower incidence of major cardiovascular events with a Mediterranean diet supplemented with extra-virgin olive oil or nuts against a reduced-fat control. Dietary pattern trials cannot be blinded and the reanalysis lowered the effect estimate, but this remains among the better-evidenced dietary interventions in cardiovascular prevention. ↩
On epidemiology and risk: American Heart Association Heart Disease and Stroke Statistics annual update. heart.org. Coronary artery disease remains the single largest cause of death in the United States and most high-income countries. ↩
On LDL cholesterol at the time of hospital admission: in the US Get With The Guidelines registry, 136,905 hospitalizations for coronary artery disease from 2000 to 2006 had cholesterol measured within 24 hours of admission; almost half had LDL below 100 mg/dL, only 17.6% had LDL below 70 mg/dL and only 21.1% had been taking cholesterol-lowering medicine, and the authors concluded that the findings may support guideline revisions with even lower LDL goals, PubMed 19081406. ↩
On plaque regression with a high-intensity statin: in the ASTEROID trial, 349 patients with coronary disease who completed 2 years of very high-intensity statin therapy, with no control group, had LDL cholesterol fall from an average 130.4 to 60.8 mg/dL and a median 6.8% reduction in total coronary atheroma volume on intravascular ultrasound; the authors said further studies were needed to determine the effect on clinical outcomes, PubMed 16533939. ↩
On how much lowering LDL cholesterol matters: a meta-analysis of individual data from 170,000 people in 26 randomized trials found that major vascular events fell by about a fifth a year for each 1 mmol/L reduction in LDL cholesterol, with the same proportional benefit in every type of patient studied and no threshold within the range covered, PubMed 21067804. ↩
On cardiac rehabilitation: a 2023 meta-analysis of 85 randomized trials in 23,430 people with coronary heart disease found that exercise-based cardiac rehabilitation lowered cardiovascular mortality (risk ratio 0.74), hospital admissions (0.77) and further heart attacks (0.82), with better quality of life and favorable cost-effectiveness, and no significant effect on all-cause mortality, PubMed 36746187. ↩
On what clogs the arteries: NHS guidance describes coronary heart disease as the buildup of fatty deposits in the coronary arteries, names smoking and regularly drinking excessive amounts of alcohol as lifestyle causes of that process, and lists high cholesterol, high blood pressure and diabetes as conditions that raise the risk, NHS, coronary heart disease. ↩
On lipoprotein(a): a 2022 European Atherosclerosis Society consensus statement found strong epidemiologic and genetic support for a causal, continuous link between Lp(a) and cardiovascular outcomes, present even at very low LDL cholesterol, recommended measuring Lp(a) at least once in adults, and, with no specific Lp(a)-lowering therapy available at the time, advised early intensive management of overall cardiovascular risk, PubMed 36036785. ↩
On coronary artery calcium: CAC scoring refines risk estimation in intermediate-risk patients and can reclassify treatment decisions in either direction. A CAC score of zero indicates low short-term risk but is not a reason to stop or decline treatment in someone with established disease or other strong indications. ↩
On statin therapy in established coronary disease: the 2018 US cholesterol guideline recommends high-intensity or maximally tolerated statin therapy for people with clinical atherosclerotic cardiovascular disease, defines high intensity as atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg, and advises a repeat lipid test 4 to 12 weeks after starting or adjusting a statin to check adherence and response, PubMed 30586774. The 2018 guideline was replaced in 2026 by a guideline that adds LDL goals by risk level (see note 16). ↩
Read the omega-⁠3 trials carefully, because the supplement and the drug are not the same thing. REDUCE-IT: Bhatt DL, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11-⁠22. PubMed 30415628. Prescription icosapent ethyl, 4 g/day of purified EPA, in statin-treated patients with elevated triglycerides: 25% relative reduction in major cardiovascular events. Then VITAL, N Engl J Med. 2019;380:23-⁠32. PubMed 30415637, and ASCEND, N Engl J Med. 2018;379:1540-⁠1550. PubMed 30146932, both large randomized trials of ordinary marine omega-⁠3 supplementation at about 1 g/day: no significant cardiovascular benefit. A fish oil capsule is not icosapent ethyl, and citing REDUCE-IT to justify one is the most common error in this area. ↩
On magnesium: the upper intake level for supplemental magnesium is 350 mg/day; above that, diarrhea is common, sometimes with nausea and cramping. Magnesium accumulates in reduced kidney function, so check with a clinician if kidney function is impaired. ↩
On sleep: a 2011 meta-analysis of 15 prospective studies in 474,684 people found short sleep associated with 1.48 times the risk of developing or dying of coronary heart disease, and long sleep with 1.38 times, PubMed 21300732. ↩
On LDL cholesterol goals: the 2026 US multisociety dyslipidemia guideline, which replaces the 2018 cholesterol guideline, sets a goal below 55 mg/dL for people with established atherosclerotic disease who are at very high risk of further events, PubMed 41824590, as summarized by the American College of Cardiology, 2026. ↩
On statin side effects quoted on this page: muscle symptoms are the common reason for discontinuation, though randomized and blinded studies consistently find far lower rates than open-label practice, and a substantial share of symptoms recur on placebo. New-onset diabetes risk is real but small in absolute terms and outweighed by cardiovascular benefit in patients with established disease. Liver enzyme elevation is usually mild and reversible. None of this is a reason to stop a statin without discussing it. ↩
On adding a cholesterol absorption blocker to a statin: in a trial of 18,144 people recently hospitalized with an acute coronary syndrome, adding it lowered average LDL cholesterol from 69.5 to 53.7 mg/dL and the 7-⁠year rate of the combined cardiovascular endpoint from 34.7% to 32.7% (hazard ratio 0.936), with similar rates of muscle, gallbladder and liver side effects, PubMed 26039521. ↩
On aspirin: routine aspirin for primary prevention is no longer recommended for most adults, because bleeding risk offsets the cardiovascular benefit in people without established disease. Secondary prevention after a cardiovascular event is a different question and is generally continued. This is a prescriber's decision, not a supplement decision. ↩
On the Mediterranean pattern: in a trial of 7,447 adults aged 55 to 80 at high cardiovascular risk but without cardiovascular disease at entry, a Mediterranean diet with extra-virgin olive oil or with mixed nuts had fewer major cardiovascular events than a reduced-fat control diet over a median 4.8 years. This is the 2018 republication after protocol deviations were found and the analysis was revised, PubMed 29897866. ↩
On plant sterols and soluble fiber: both lower LDL cholesterol modestly and reproducibly, with a meta-analysis of phytosterol-fortified foods confirming the LDL reduction, PubMed 37225641, which is why soluble fiber appears here while several better-marketed supplements do not. Neither has been shown in a randomized trial to reduce cardiovascular events. ↩
Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
On CoQ10 and statin muscle symptoms, the trials genuinely disagree. A systematic review and meta-analysis of 7 randomized trials in 321 patients found no benefit for statin-associated myalgia or statin adherence, Atherosclerosis, PubMed 32179207; only two of the studies it reviewed showed any positive effect. An updated meta-analysis of 12 randomized trials in 575 patients found CoQ10 reduced muscle pain, weakness, cramp and tiredness, J Am Heart Assoc, PubMed 30371340. The trials are small and heterogeneous, which is why the answer is unsettled. Separately, Q-SYMBIO reported fewer major adverse cardiovascular events with CoQ10 in heart failure (n = 420), a different population from stable coronary disease. ↩
On CoQ10 and other medicines: the NIH National Center for Complementary and Integrative Health states that CoQ10 may interact with a commonly used blood thinner and with insulin, NCCIH, Coenzyme Q10. ↩
On vitamin K2: in the Rotterdam Study of 4,807 adults without a previous heart attack, those in the top third of dietary menaquinone (vitamin K2) intake had a relative risk of coronary heart disease death of 0.43 compared with the bottom third, and less severe aortic calcification. This is an observational finding about food, not a trial of supplements, PubMed 15514282. ↩
On berberine and lipids: a 2025 meta-analysis of randomized placebo-controlled trials in metabolic syndrome found berberine lowered triglycerides by about 0.37 mmol/L, fasting glucose by about 0.52 mmol/L and LDL cholesterol by about 0.50 mmol/L, with no significant effect on HDL cholesterol or blood pressure, and called for more high-quality trials, PubMed 40740996. ↩
On nitrate and beet juice: a 2013 meta-analysis of 16 short crossover trials in 254 participants found systolic pressure about 4.4 mmHg lower with inorganic nitrate or beet juice than with placebo, and called for longer trials in people at higher cardiovascular risk, PubMed 23596162. ↩
On vitamin D: in a randomized trial of 25,871 US adults followed for a median 5.3 years, 2,000 IU of vitamin D3 a day did not lower major cardiovascular events (hazard ratio 0.97) or heart attack (0.96) compared with placebo, PubMed 30415629. ↩
On the emergency and on recovery: NHS guidance advises calling emergency services for chest pain that feels tight or like squeezing, chest pain spreading to the arms, neck or jaw, severe difficulty breathing, lips or skin turning pale, blue or gray, or anyone who has passed out and is not responding normally, and not to drive yourself. It lists further warning signs, including sudden new breathlessness and chest pain with nausea or a racing, slow or skipping heartbeat. Hospital treatment may include medicines to treat the blockage, a stent or bypass surgery, and recovery ranges from several weeks to months or years, NHS, heart attack. ↩
On chest pain as an emergency in the US: the CDC lists chest pain or discomfort first among the major symptoms of a heart attack, names nausea or vomiting among the other symptoms, and advises calling 911 immediately for heart attack symptoms, CDC, heart attack. ↩
National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩

Symptom	What happens
Classic Cardiac Symptoms
Chest Pain or Pressure (Angina)	Substernal pressure, squeezing, heaviness, often described as "an elephant on my chest." May radiate to left arm, neck, jaw or back. Stable angina is triggered by exertion; unstable comes on at rest. Worsening pattern is an emergency.
Shortness of Breath on Exertion	Heart muscle starved of oxygen can't pump effectively. May occur without chest pain, especially in women and diabetics. New-onset breathlessness with previously tolerable activity warrants cardiac workup.
Palpitations & Irregular Rhythm	Ischemic heart muscle is electrically unstable. New palpitations or fluttering, especially with exertion, can indicate developing CAD. Atrial fibrillation often co-occurs.
Cold Sweats & Clamminess	Sudden, drenching sweat unrelated to environment or activity, especially with other cardiac symptoms, often heralds an acute coronary event. Sympathetic surge response to ischemia.
Atypical & Warning Signs
Nausea, Indigestion or Vague Upper Abdominal Discomfort	More common in women, diabetics and the elderly. Heart attacks frequently mistaken for heartburn. If new and unexplained, especially with exertion, get evaluated.
Unexplained Fatigue & Weakness	Especially in women, profound new fatigue weeks before a cardiac event is well documented. Reflects reduced cardiac output. "I just couldn't do my normal walk" is a red flag.
Jaw, Neck, Back or Arm Pain	Referred pain from cardiac ischemia. Left arm classic, but can be either arm, jaw, neck or upper back. Pain without obvious orthopedic cause, especially with exertion, must be evaluated cardiac-first.
Lightheadedness, Syncope or Near-Fainting	Reduced cardiac output OR arrhythmia. Syncope in someone with cardiac risk factors is high-stakes: it could be ventricular tachycardia or severe ischemia. ALWAYS evaluate.

Test	What it shows
Advanced Lipid Panel (Foundation)
ApoB & LDL Particle Number (LDL-P)	ApoB measures every atherogenic particle directly. Better predictor than standard LDL-C. Optimal: <80 mg/dL (high-risk <60). When LDL-C and particle count disagree, ApoB can predict risk better; ask whether it is right for you.
Lipoprotein(a), Lp(a)	Genetically determined, and a cause of cardiovascular disease in its own right, even when LDL cholesterol is very low. Test it at least once in adult life. The 2022 consensus found no specific Lp(a)-lowering therapy, so a high level calls for early, intensive control of every other risk factor¹⁰.
hs-CRP (Inflammation Marker)	High-sensitivity CRP measures systemic inflammation. <1.0 mg/L low risk; 1.0 to 3.0 average; >3.0 high. The CANTOS trial showed an anti-inflammatory drug reduced cardiac events without lowering cholesterol.
Imaging & Functional Tests
Coronary Calcium Score (CAC)	Non-contrast CT directly visualizes calcified plaque. Score 0: minimal risk; 1 to 99: mild; 100 to 399: moderate; ≥400: high. A strong predictor of future cardiac events, used mainly to refine risk in intermediate-risk adults¹¹.
CT Coronary Angiography (CTCA)	Contrast CT visualizes coronary anatomy, including non-calcified (soft) plaque, the more dangerous type. Now first-line for evaluating chest pain in many guidelines. Non-invasive alternative to cardiac catheterization.
Stress Test (Exercise or Pharmacologic)	Treadmill ECG, stress echo or nuclear (myocardial perfusion). Detects significant blockages by inducing ischemia. Best for symptomatic patients with intermediate risk.
Cardiac Catheterization	Invasive gold standard. Reserved for those with abnormal non-invasive tests, ongoing symptoms or suspected ACS. Allows direct measurement and immediate intervention (stent) if needed.

What to eat or do	Details
✅ Prioritize These:
Fatty Fish 3x/week	Wild salmon, sardines, Atlantic mackerel, anchovies. Eating fatty fish is linked with lower heart risk, and its EPA/DHA omega-⁠3s help lower triglycerides. Wild-caught preferred.
Extra-Virgin Olive Oil	2 to 3 tablespoons (30 to 45 mL) daily. Polyphenols (oleocanthal, oleuropein) have anti-inflammatory effects in studies, and olive oil was part of the PREDIMED diet²⁰.
Nuts, 1 Ounce (28 g) a Day	Walnuts, almonds, pistachios, hazelnuts. Heart-healthy fats, fiber, magnesium. In PREDIMED, which enrolled high-risk adults without heart disease, a Mediterranean diet supplemented with mixed nuts had about 28% fewer major cardiovascular events than a reduced-fat diet (hazard ratio 0.72)²⁰.
Vegetables & Legumes	Leafy greens (nitrates → nitric oxide for endothelial function), beans, lentils, chickpeas. Soluble fiber binds cholesterol²¹; nitrates dilate arteries.
❌ Limit or Eliminate:
Refined Carbs & Sugar	Drive small-dense LDL formation, insulin resistance, triglyceride elevation. White bread, pasta, rice, sweets, soda.
Deep-Fried Foods & Trans Fats	Deep-fried and packaged foods are the concern, not soybean, corn, cottonseed or other vegetable oils themselves. Avoid fried fast food, packaged snacks and any product with partially hydrogenated oil.
Processed & Cured Meats	Bacon, sausage, deli meats, hot dogs. Nitrates/nitrites, advanced glycation end products, high sodium. Strongly linked to CV mortality.
Excess Saturated Fat (Contextually)	Especially as PART of a processed-food diet. Replace with monounsaturated (olive oil) and omega-⁠3 fats. Coconut oil raises LDL significantly; minimize it.

Coronary Artery Disease

What Is Coronary Artery Disease?

Spectrum of Coronary Artery Disease

Stable Angina

Acute Coronary Syndrome

Ischemic Cardiomyopathy